Thomas Templeman - Net Worth and Insider Trading
Thomas Templeman Net Worth
The estimated net worth of Thomas Templeman is at least $2 Million dollars as of 2024-11-10. Thomas Templeman is the Chief Technology Officer of Centessa Pharmaceuticals PLC and owns about 135,792 shares of Centessa Pharmaceuticals PLC (CNTA) stock worth over $2 Million. Details can be seen in Thomas Templeman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Templeman has not made any transactions after 2022-10-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Templeman
Thomas Templeman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Templeman owns 2 companies in total, including Nuvation Bio Inc (NUVB) , and Centessa Pharmaceuticals PLC (CNTA) .
Click here to see the complete history of Thomas Templeman’s form 4 insider trades.
Insider Ownership Summary of Thomas Templeman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NUVB | Nuvation Bio Inc | 2021-02-10 | SVP & Pharmaceutical Ops |
| CNTA | Centessa Pharmaceuticals PLC | 2022-10-03 | Chief Technology Officer |
Thomas Templeman Latest Holdings Summary
Thomas Templeman currently owns a total of 1 stock. Thomas Templeman owns 135,792 shares of Centessa Pharmaceuticals PLC (CNTA) as of October 3, 2022, with a value of $2 Million.
Latest Holdings of Thomas Templeman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals PLC | 2022-10-03 | 135,792 | 16.50 | 2,240,568 |
Holding Weightings of Thomas Templeman
Thomas Templeman Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Templeman has made a total of 1 transactions in Centessa Pharmaceuticals PLC (CNTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Centessa Pharmaceuticals PLC is the sale of 4,458 shares on October 3, 2022, which brought Thomas Templeman around $17,832.
Insider Trading History of Thomas Templeman
- 1
Thomas Templeman Trading Performance
Thomas Templeman Ownership Network
Ownership Network List of Thomas Templeman
Ownership Network Relation of Thomas Templeman
Thomas Templeman Owned Company Details
What does Nuvation Bio Inc do?
Who are the key executives at Nuvation Bio Inc?
Thomas Templeman is the SVP & Pharmaceutical Ops of Nuvation Bio Inc. Other key executives at Nuvation Bio Inc include Chief Medical Officer Dongfang Liu , 10 percent owner Omega Fund V Gp, L.p. , and 10 percent owner Omega Fund Iv Gp, L.p. .
Nuvation Bio Inc (NUVB) Insider Trades Summary
Over the past 18 months, Thomas Templeman made no insider transaction in Nuvation Bio Inc (NUVB). Other recent insider transactions involving Nuvation Bio Inc (NUVB) include a net purchase of 777,895 shares made by Xiangmin Cui , a net purchase of 5,313,100 shares made by Oleg Nodelman , and a net purchase of 172,189 shares made by Kim D Blickenstaff .
In summary, during the past 3 months, insiders sold 0 shares of Nuvation Bio Inc (NUVB) in total and bought 100,000 shares, with a net purchase of 100,000 shares. During the past 18 months, 0 shares of Nuvation Bio Inc (NUVB) were sold and 6,363,184 shares were bought by its insiders, resulting in a net purchase of 6,363,184 shares.
Nuvation Bio Inc (NUVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nuvation Bio Inc Insider Transactions
Thomas Templeman Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Templeman. You might contact Thomas Templeman via mailing address: C/o Centessa Pharmaceuticals Plc, 3rd Floor, 1 Ashley Road, Altrincham, Cheshire X0 Wa14 2dt.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
